Invention Grant
- Patent Title: High affinity human antibodies to human nerve growth factor
- Patent Title (中): 人类神经生长因子高亲和力抗体
-
Application No.: US13166905Application Date: 2011-06-23
-
Publication No.: US08148107B2Publication Date: 2012-04-03
- Inventor: Lynn Macdonald , Richard Torres , Marc R. Morra , Joel H. Martin , Joel C. Reinhardt
- Applicant: Lynn Macdonald , Richard Torres , Marc R. Morra , Joel H. Martin , Joel C. Reinhardt
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agent Valeta Gregg, Esq.; Veronica Mallon
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/13 ; C12N5/10 ; C12N5/07 ; C12N1/21

Abstract:
A human antibody or antigen-binding fragment of an antibody which specifically binds human nerve growth factor (NGF) with KD of 5 pM or less, as measured by surface plasmon resonance, wherein the antibody or fragment thereof binds human NGF with an affinity of about 2-10-fold higher than the antibody or fragment binds rat and mouse NGF. The antibodies are useful in treating pain, including inflammatory pain, post-operative incision pain, neuropathic pain, fracture pain, osteoporotic fracture pain, post-herpetic neuralgia, osteoarthritis, rheumatoid arthritis, cancer pain, pain resulting from burns, gout joint pain, as well as diseases, such as hepatocellular carcinoma, breast cancer, and liver cirrhosis.
Public/Granted literature
- US20110256587A1 HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN NERVE GROWTH FACTOR Public/Granted day:2011-10-20
Information query